Tumor-Derived Exosomes: The Next Generation of Promising Cell-Free Vaccines in Cancer Immunotherapy

Tumor-Derived Exosomes: The Next Generation of Promising Cell-Free Vaccines in Cancer Immunotherapy Publisher Pubmed

Naseri M^{1, 2} ; Bozorgmehr M² ; Zoller M³ ; Ranaei Pirmardan E⁴ ; Madjd Z^{1, 2}

Show Affiliations

1. Department of Molecular Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran
2. Oncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran
3. Section Pancreas Research, University Hospital of Surgery, Heidelberg, Germany
4. Molecular Biomarkers Nano-imaging Laboratory, Brigham & Womenâ€™s Hospital, Department of Radiology, Harvard Medical School, Boston, MA, United States

Source: OncoImmunology Published:2020

Abstract

Identification of immunogenic tumor antigens that are efficiently processed and delivered by dendritic cells to prime the immune system and to induce an appropriate immune response is a research hotspot in the field of cancer vaccine development. High biosafety is an additional demand. Tumor-derived exosomes (TEXs) are nanosized lipid bilayer encapsulated vesicles that shuttle bioactive information to the tumor microenvironment facilitating tumor progression. However, accumulating evidence points toward the capacity of TEXs to efficiently stimulate immune responses against tumors provided they are appropriately administered. After briefly describing the function of exosomes in cancer biology and their communication with immune cells, we summarize in this review in vitro and preclinical studies eliciting the potency of TEXs in inducing effective anti-tumor responses and recently modified strategies further improving TEX-vaccination efficacy. We interpret the available data as TEXs becoming a lead in cancer vaccination based on tumor antigen-selective high immunogenicity. © 2020, © 2020 The Author(s). Published with license by Taylor & Francis Group, LLC.

Related Docs

View other Related Docs

1. Exosomes and Micrornas in Biomedical Science, Synthesis Lectures on Biomedical Engineering (2022)

2. Dendritic Cells Loaded With Exosomes Derived From Cancer Stem Cell-Enriched Spheroids As a Potential Immunotherapeutic Option, Journal of Cellular and Molecular Medicine (2021)

3. Texosome-Based Drug Delivery System for Cancer Therapy: From Past to Present, Cancer Biology and Medicine (2015)

4. Exosomes and Lung Cancer: Roles in Pathophysiology, Diagnosis and Therapeutic Applications, Current Medicinal Chemistry (2021)

5. Communication Between Stromal and Hematopoietic Stem Cell by Exosomes in Normal and Malignant Bone Marrow Niche, Biomedicine and Pharmacotherapy (2020)

6. Tumor-Derived Exosomal Micrornas and Proteins As Modulators of Macrophage Function, Journal of Cellular Physiology (2019)

7. Extracellular Vesicles Biogenesis, Isolation, Manipulation and Genetic Engineering for Potential in Vitro and in Vivo Therapeutics: An Overview, Frontiers in Bioengineering and Biotechnology (2022)

8. Engineered Tumor-Derived Extracellular Vesicles: Potentials in Cancer Immunotherapy, Frontiers in Immunology (2020)

Experts (# of related papers)

View all Related Experts

Hamid Reza Mirzaei (10)

Nima Rezaei (5)

Style	Citing Format
MLA	Naseri M, et al.. "Tumor-Derived Exosomes: The Next Generation of Promising Cell-Free Vaccines in Cancer Immunotherapy." OncoImmunology, vol. 9, no. 1, 2020, pp. -.
APA	Naseri M, Bozorgmehr M, Zoller M, Ranaei Pirmardan E, Madjd Z (2020). Tumor-Derived Exosomes: The Next Generation of Promising Cell-Free Vaccines in Cancer Immunotherapy. OncoImmunology, 9(1), -.
Chicago	Naseri M, Bozorgmehr M, Zoller M, Ranaei Pirmardan E, Madjd Z. "Tumor-Derived Exosomes: The Next Generation of Promising Cell-Free Vaccines in Cancer Immunotherapy." OncoImmunology 9, no. 1 (2020): -.
Harvard	Naseri M et al. (2020) 'Tumor-Derived Exosomes: The Next Generation of Promising Cell-Free Vaccines in Cancer Immunotherapy', OncoImmunology, 9(1), pp. -.
Vancouver	Naseri M, Bozorgmehr M, Zoller M, Ranaei Pirmardan E, Madjd Z. Tumor-Derived Exosomes: The Next Generation of Promising Cell-Free Vaccines in Cancer Immunotherapy. OncoImmunology. 2020;9(1):-.
BibTex	@article{ author = {Naseri M and Bozorgmehr M and Zoller M and Ranaei Pirmardan E and Madjd Z}, title = {Tumor-Derived Exosomes: The Next Generation of Promising Cell-Free Vaccines in Cancer Immunotherapy}, journal = {OncoImmunology}, volume = {9}, number = {1}, pages = {-}, year = {2020} }
RIS	TY - JOUR AU - Naseri M AU - Bozorgmehr M AU - Zoller M AU - Ranaei Pirmardan E AU - Madjd Z TI - Tumor-Derived Exosomes: The Next Generation of Promising Cell-Free Vaccines in Cancer Immunotherapy JO - OncoImmunology VL - 9 IS - 1 SP - EP - PY - 2020 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract